Theralase Technologies (TLT) News Today → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free TLT Stock Alerts C$0.16 -0.01 (-3.03%) (As of 05:33 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTheralase Technologies Inc.: Theralase Closes $CAN 750,000 Non-Brokered Private Placementfinanznachrichten.de - April 24 at 8:36 AMTheralase Technologies Inc.: Theralase Granted Canadian Cancer Vaccine Patentfinanznachrichten.de - April 5 at 9:32 AMTheralase(R) Granted Canadian Cancer Vaccine Patentfinance.yahoo.com - April 5 at 9:32 AMTheralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Associationfinance.yahoo.com - March 26 at 8:18 AMClosing Bell: Theralase Technologies Inc flat on Friday (TLT)theglobeandmail.com - March 16 at 4:39 AMTheralase Technologies Inc TLTmorningstar.com - March 1 at 8:30 AMTheralase Technologies Inc.: Theralase Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Diseasefinanznachrichten.de - February 12 at 8:50 AMTheralase(R) Donates Cool Laser Therapy Technology to Aid in Research and Development of a Treatment for Parkinson's Diseasefinance.yahoo.com - February 12 at 8:50 AMDr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in the Phase II Non-Muscle Invasive Bladder Cancer Clinical Studyfinance.yahoo.com - February 8 at 7:43 AMTheralase Technologies Inc.: Theralase Closes $CAN 1.2 Million Non-Brokered Private Placementfinanznachrichten.de - February 5 at 6:22 PMTheralase(R) Closes $CAN 1.2 Million Non-Brokered Private Placementfinance.yahoo.com - February 5 at 6:22 PMTheralase Technologies Inc.: Theralase Provides Update on Phase II Bladder Cancer Clinical Studyfinanznachrichten.de - January 15 at 12:19 PMTheralase makes positive progress on Phase II study on...Theralase makes positive progress on Phase II study on bladder...proactiveinvestors.com - December 1 at 6:24 PMTheralase concludes $1.17M private placement for cancer treatment advancementsproactiveinvestors.com - November 30 at 2:51 PMTheralase focused on breakthrough designation after positive preliminary study dataproactiveinvestors.com - November 30 at 2:51 PMTheralase Technologies Inc.: Theralase Release's 3Q2023 Interim Financial Statementsfinanznachrichten.de - November 29 at 11:16 PMTheralase Release's 3Q2023 Interim Financial Statementsfinance.yahoo.com - November 29 at 11:16 PMTheralase Technologies Inc.: Theralase Closes $CAN 1.17 Million Non-Brokered Private Placementfinanznachrichten.de - November 29 at 6:16 PMTheralase Technologies Inc.: Theralase Commences Non-Brokered Private Placement and Termination of Previously Announced Financingfinanznachrichten.de - November 17 at 5:46 PMTheralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financingfinance.yahoo.com - November 17 at 5:46 PMTheralase(R) Announces Brokered LIFE Financingbenzinga.com - October 23 at 10:44 PMTheralase(R) Optimizes Phase II Bladder Cancer Clinical Studyfinance.yahoo.com - October 23 at 7:42 AMTheralase(R) Provides Update on Bladder Cancer Clinical Studyfinance.yahoo.com - October 16 at 7:33 AMClosing Bell: Theralase Technologies Inc WT up on Friday (TLT-WT)theglobeandmail.com - October 10 at 8:36 AMTheralase(R) Files US Patent for Enhanced Immunotherapyfinance.yahoo.com - October 5 at 9:29 AMTheralase Technologies Inc.: Theralase Demonstrates 8 Year Shelf Life of Lead Drug Ruvidarfinanznachrichten.de - September 29 at 12:54 PMTheralase(R) Demonstrates 8 Year Shelf Life of Lead Drug Ruvidar(TM)finance.yahoo.com - September 29 at 12:54 PMTheralase Technologies Inc.: Theralase Successfully Completes Non-GLP Toxicity Analysis for Brain Cancerfinanznachrichten.de - September 27 at 8:11 AMTheralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain Cancerfinance.yahoo.com - September 27 at 8:11 AMTheralase(R) Grants Stock Optionsfinance.yahoo.com - September 21 at 6:05 PMTheralase(R) Closes Private Placement Equity Financingfinance.yahoo.com - September 7 at 7:42 PMClosing Bell: Theralase Technologies Inc up on Tuesday (TLT)theglobeandmail.com - September 5 at 10:26 PMTheralase Technologies (TLT) Earnings Dates & Reportsinvesting.com - August 29 at 11:02 PMTheralase Technologies Inc.: Theralase Release's 2Q2023 Interim Financial Statementsfinanznachrichten.de - August 29 at 6:01 PMTheralase Release’s 2Q2023 Interim Financial Statementsfinance.yahoo.com - August 29 at 6:01 PMClosing Bell: Theralase Technologies Inc WT flat on Thursday (TLT-WT)theglobeandmail.com - August 25 at 4:33 AMClosing Bell: Theralase Technologies Inc WT up on Tuesday (TLT-WT)theglobeandmail.com - August 24 at 7:40 AMTLT:CA Theralase Technologies Inc.seekingalpha.com - August 22 at 6:23 PMTheralase Technologies Inc. (TLTFF)finance.yahoo.com - August 21 at 9:23 PMClosing Bell: Theralase Technologies Inc up on Monday (TLT)theglobeandmail.com - August 21 at 9:23 PMClosing Bell: Theralase Technologies Inc WT down on Thursday (TLT-WT)theglobeandmail.com - July 29 at 5:47 PMClosing Bell: Theralase Technologies Inc flat on Tuesday (TLT)theglobeandmail.com - July 19 at 12:40 PMClosing Bell: Theralase Technologies Inc WT down on Monday (TLT-WT)theglobeandmail.com - July 18 at 3:29 PMTheralase Technologies Inc.: Theralase Closes Non-Brokered Private Placement Equity Financingfinanznachrichten.de - June 30 at 7:16 PMTheralase(R) Closes Non-Brokered Private Placement Equity Financingfinance.yahoo.com - June 30 at 7:16 PMClosing Bell: Theralase Technologies Inc WT flat on Wednesday (TLT-WT)theglobeandmail.com - June 22 at 11:18 PMTheralase Technologies Inc.: Theralase Releases 1Q2023 Interim Financial Statementsfinanznachrichten.de - May 30 at 10:51 PMTheralase Technologies Inc.: Theralase Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statementsfinanznachrichten.de - May 30 at 10:51 PMTheralase(R) Releases 1Q2023 Interim Financial Statementsfinance.yahoo.com - May 30 at 10:51 PMTheralase(R) Releases Corrected and Restated Press Release for 1Q2023 Interim Financial Statementsfinance.yahoo.com - May 30 at 10:51 PM Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Protect Yourself While There’s Still Time … (Ad)The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom. 4 simple steps to protect your privacy and money before it’s too late. TLT Media Mentions By Week TLT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TLT News Sentiment▼0.000.32▲Average Medical News Sentiment TLT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TLT Articles This Week▼11▲TLT Articles Average Week Get Theralase Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for TLT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VentriPoint Diagnostics News Aurora Spine News MedX Health News Reliq Health Technologies News HEXO News Akumin News Charlotte's Web News IBEX Technologies News Microbix Biosystems News MediPharm Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:TLT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theralase Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.